3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Inhibition, Psychological
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Hepatoblastoma
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
Gemcitabine
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
8
Cisplatin
7
pembrolizumab
6
Radiation
5
Mitomycin
4
Fluorouracil
4
Cystoscopy
4
enfortumab vedotin
3
durvalumab
3
dehydroftorafur
3
avelumab
3
Transurethral Resection of Bladder
3
Radiotherapy
3
Platinum
3
Nivolumab
3
Mitozytrex
3
Cystectomy
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
tremelimumab
2
erdafitinib
2
atezolizumab
2
Paclitaxel
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
Carboplatin
2
Biopsy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
tazemetostat
×
30 days
×
Clear all
No trials found.